Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study

BACKGROUND: The presence of autoantibodies in the serum of cancer patients has been associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related adverse events (irAEs). A prospective evaluation of different autoantibodies in different cancer entities is missing. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Dominik A., Stanzer, Stefanie, Spiegelberg, Jasmin, Bauernhofer, Thomas, Absenger, Gudrun, Posch, Florian, Lipp, Rainer, Halm, Michael, Szkandera, Joanna, Balic, Marija, Gerger, Armin, Smolle, Maria A., Hutterer, Georg C., Klec, Christiane, Jost, Philipp J., Kargl, Julia, Stradner, Martin, Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385593/
https://www.ncbi.nlm.nih.gov/pubmed/35297215
http://dx.doi.org/10.1002/cam4.4675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385593/
https://www.ncbi.nlm.nih.gov/pubmed/35297215
http://dx.doi.org/10.1002/cam4.4675

Ejemplares similares